Ybrain Introduces BCI Platform in Keynote at International BCI Symposium

Neuroengineering solution company Ybrain announced on the 12th that CEO Giwon Lee delivered a keynote speech as the Korean representative at the 1st International BCI Symposium hosted by the Brain-Computer Interface (BCI) International Standardization Committee (ISO/IEC JTC1/SC43) held on the 6th in Hangzhou, Zhejiang Province, China. This meeting was jointly hosted by the BCI International Standardization Committee, Zhejiang University, China Electronics Standardization Institute, and Hangzhou Standardization Institute.

Lee Gi-won, CEO of Ybrain, is introducing Ybrain's BCI system through a keynote speech as a domestic representative at the 1st BCI International Symposium held in Hangzhou, Zhejiang Province, China.
[Photo by Ybrain]

BCI is a technology that directly connects the brain and computers. Recently, combined with artificial intelligence (AI) technology, it has been developing into technology that helps patients with stroke or amyotrophic lateral sclerosis (ALS) communicate or control assistive devices using only their thoughts. Although various BCI technologies are being developed worldwide, there is no standardized data format, so the developed devices are not efficiently interoperable.

This event was held to establish international standards for BCI. Forty-three international experts and more than 200 representatives from companies and research institutions from countries including the United States, Korea, Australia, India, Italy, Finland, and Japan attended. The keynote speeches at this event featured a total of seven experts from the United States, Korea, Australia, and other countries, presenting on topics such as the current status of BCI technology, related product development, interoperability and ethics, and commercialization.

As the domestic representative speaker, Ybrain CEO Giwon Lee attended and focused on introducing the BCI system established by Ybrain in Korea. Currently, the two pillars of Ybrain's BCI system are the EEG measurement device 'MindScan' and the electronic medicine for depression 'MindSteam.' MindScan is used as a diagnostic aid utilizing biometric signals and is covered by insurance, while MindSteam has succeeded in commercialization as a non-insurance product and is prescribed in hospitals.

Ybrain's BCI system provides personalized treatment using MindSteam based on EEG data collected through MindScan. The data between the brain and computer used for diagnostic assistance and depression treatment is continuously accumulated to improve treatment.

So far, MindScan is being used for 7,230 measurements per month at 238 hospitals and clinics nationwide, with a cumulative total of 117,970 measurements. MindSteam is being used for 3,500 treatments per month at 94 hospitals and clinics nationwide, with a cumulative total of 39,870 prescriptions.

Giwon Lee, CEO of Ybrain, said, "We are very honored to contribute to the establishment of international BCI standards through Ybrain's leading BCI system," and added, "We also plan to successfully lead the official ISO review in November regarding the real-world use cases of MindScan and MindSteam in diagnosis and treatment settings."

This content was produced with the assistance of AI translation services.